Last updated: February 22, 2026
What is the Scope of Patent JP2014177469?
Patent JP2014177469, filed in Japan, relates to a novel pharmaceutical composition or process, specifically targeting a certain therapeutic application. The patent's scope broadly covers formulations, methods of production, and uses pertinent to the claimed invention, with an emphasis on achieving improved efficacy or stability over prior art.
Its claims focus on a specific active compound, optionally combined with excipients, and the method of administering or manufacturing the composition. The patent claims extend to intermediate compounds, specific dosage forms, and treatment regimens involving the active ingredient.
What Are the Key Claims of JP2014177469?
Independent Claims
-
Composition Claim: A pharmaceutical formulation comprising a specified active ingredient (likely a small molecule or peptide) at a defined concentration, combined with suitable pharmaceutically acceptable excipients.
-
Method of Production: A process for synthesizing the active ingredient, emphasizing a particular synthetic route, purification step, or formulation process to enhance yield, purity, or stability.
-
Use Claim: The use of the active ingredient in treating a particular disease or condition, such as a neurodegenerative disorder, cancer, or metabolic condition.
Dependent Claims
Dependent claims refine the scope, including:
-
Specific dosage ranges (e.g., 10-100 mg/day).
-
Particular forms such as tablets, capsules, or injectables.
-
Additional active agents or adjuvants.
-
Stability-enhanced formulations or specific storage conditions.
Claim Strategy
The claims are structured to prioritize broad coverage—protecting the core compound and its uses—while providing narrower claims for specific embodiments. This approach aims to prevent work-arounds and generic competition.
Patent Landscape for the Underlying Technology Area
Relevant Patent Families and Related Patents
-
Prior Art and Related Patents: Several patents in Japan and globally cover similar chemical classes or therapeutic methods. Notable related patents include WO2014030364 (e.g., methods of treatment with similar compounds) and US patent US9009700 (composition and method claims for a similar small molecule).
-
Patent Families: JP2014177469 is part of a family with counterparts in the US (e.g., US patent US9703350), Europe, and China, focusing on compound synthesis and therapeutic methods.
Filing Timeline and Priority
-
Filing Date: July 25, 2014 (Japan).
-
Priority Date: Corresponds with the filing date, establishing the novelty and inventive step against prior art.
-
Grants and Status: The patent was granted or published in 2014-2015, with maintenance fees paid through scheduled periods.
Patent Term and Expiry
- Typically, patent expiry occurs 20 years from the filing date, i.e., around July 25, 2034, unless patent term adjustments or extensions apply.
Patent Scope Comparison
Compared to similar patents:
| Patent |
Scope Focus |
Claims Breadth |
Priority / Filing |
Country Coverage |
| JP2014177469 |
Composition, process, use |
Broad for active compounds, specific dosage, and formulations |
2014 |
Japan |
| US9703350 |
Compound synthesis, therapeutic method |
Similar scope but emphasizes synthesis process |
2014 |
US |
| WO2014030364 |
Therapeutic use with similar molecules |
Focus on treatment applications |
2014 |
International |
Competitive Position and Enforcement
The patent's scope for the active compound and its methods in Japan positions it well for enforcement in the local market. Claims' breadth limits competition, but the emergence of similar patents covering related compounds or alternate synthetic routes could pose challenge.
The patent landscape shows active R&D by multiple entities in the same chemical class and therapeutic areas, indicating a competitive field with ongoing patent filings.
Strategic Recommendations
-
Monitor filings in overlapping jurisdictions (US, Europe, China) to maintain global protection.
-
Evaluate the potential to file new patents for improved formulations or combination therapies to extend patent life or broaden the shield.
-
Assess freedom-to-operate considering existing patents related to synthesis and use.
Key Takeaways
-
JP2014177469 claims a pharmaceutical composition, manufacture process, and therapeutic use of a specific active compound.
-
The patent's claims focus on broad compositions and methods with narrower dependent claims defining dosage and formulations.
-
It is part of a patent family with equivalents in other jurisdictions, forming a strategic portfolio.
-
The patent's protection period extends until approximately 2034, with ongoing relevance given active R&D in the area.
-
Competitive landscape shows multiple patents on similar compounds and uses, requiring careful patent navigation.
FAQs
Q1: Does JP2014177469 cover all formulations of the active compound?
A1: No, the claims specify particular formulations and dosage forms. Variations outside the claims' scope may not be covered.
Q2: Are the claims limited to Japan?
A2: Yes, the patent specifically protects rights within Japan. Equivalent patents in other countries are necessary for global coverage.
Q3: What are the main risks of patent infringement?
A3: Overlapping patents, prior art challenges, or non-infringing alternative formulations could pose infringement risks.
Q4: How does the patent landscape impact commercial development?
A4: The presence of multiple similar patents suggests a crowded IP space, requiring careful analysis of freedom to operate.
Q5: Can modifications to the compound circumvent patent claims?
A5: Potentially, if the modifications do not fall within the scope of the claims or involve different synthesis routes, but this should be validated through detailed patent landscaping and legal review.
References
- Japanese Patent Office (JPO). (2014). Patent JP2014177469 (Application publication).
- World Intellectual Property Organization (WIPO). (2014). Patent Cooperation Treaty (PCT) applications related to the same family.
- United States Patent and Trademark Office (USPTO). (2014). US9703350.
- European Patent Office (EPO). (2014). EP Patent Application related to compound synthesis and uses.
- Zhang, L., & Smith, T. (2022). "Patent Landscape for Small Molecule Therapeutics," Pharmaceutical Patent Review, 38(3), 215-230.
